VEGF antagonist compositions and uses thereof
US9441029B2 · kind B2 · utility
5Cited by
26References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 2011 |
| Grant date | Sep 13, 2016 |
| Priority date | — |
| Expiry date | Mar 17, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y207/10001
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods for treating a disease or disorder associated with vascular endothelial growth factor (VEGF). Specifically, the invention relates to an oligomerized VEGF binding domain to provide VEGF antagonism, and thereby treat diseases associated thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.